BRIEF published on 08/06/2024 at 09:05, 2 years 1 month ago Northern Data Group announces Q2 Results, reaffirms 2024 guidance Revenue Growth Q2 Results Capital Raise Nvidia GPUs HPC Infrastructure
BRIEF published on 08/06/2024 at 09:05, 2 years 1 month ago Northern Data Group annonce ses résultats du deuxième trimestre et réaffirme ses prévisions pour 2024 Augmentation De Capital Hausse Des Revenus Résultats Du Deuxième Trimestre GPU Nvidia Infrastructure HPC
BRIEF published on 08/06/2024 at 08:36, 2 years 1 month ago Cherry SE Releases 2024 Half-Year Report Adjusted EBITDA Revenue Growth Half-year Report Cherry SE 2024 Forecast
BRIEF published on 08/06/2024 at 08:36, 2 years 1 month ago Cherry SE publie son rapport semestriel 2024 Prévisions 2024 EBITDA Ajusté Hausse Des Revenus Cerise SE Rapport Semestriel
BRIEF published on 08/06/2024 at 08:35, 2 years 1 month ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax Obefazimod Rectocolite Hémorragique Essai Clinique Recrutement Patients
BRIEF published on 08/06/2024 at 08:35, 2 years 1 month ago Abivax Reaches Key Milestone with Recruitment of 600 Patients for Phase 3 ABTECT Trial Patient Recruitment Abivax Obefazimod Ulcerative Colitis Clinical Test
BRIEF published on 08/06/2024 at 08:35, 2 years 1 month ago Cie du Bois Sauvage : Rachat d’actions propres – semaine du 29/07/2024 au 02/08/2024 Actions Propres Rachat D'actions Bois Sauvage Transactions Boursières NYSE Euronext
BRIEF published on 08/06/2024 at 08:35, 2 years 1 month ago Cie du Bois Sauvage: Buy Back of Own Shares – Week from 29/07/2024 to 02/08/2024 Share Buyback Bois Sauvage Stock Market Brussels Financial Release
BRIEF published on 08/06/2024 at 08:35, 2 years 1 month ago Valneva Announces Share and Voting Right Changes as of July 31, 2024 Euronext Paris Voting Rights Shares Biopharmaceutical Valneva
BRIEF published on 08/06/2024 at 08:35, 2 years 1 month ago Valneva annonce des modifications au titre du capital et des droits de vote au 31 juillet 2024 Euronext Paris Actions Biopharmaceutique Droit De Vote Valneva
Published on 09/11/2026 at 04:00, 5 hours 4 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 39 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 44 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 4 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 08:15, 49 minutes ago EQS-Adhoc: Airbus SE: Airbus commences limited share buyback to support future employee share ownership plan activities and equity-based compensation
Published on 09/11/2026 at 08:02, 1 hour 1 minute ago PUMA CCO Matthias Baeumer to step down from Management Board
Published on 09/11/2026 at 07:30, 1 hour 33 minutes ago NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 00:05, 8 hours 58 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 07:00, 2 hours 4 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 4 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 34 minutes ago Availability of the 2026 Interim Financial Report
